Suzhou Sanegene Bio Inc.
Clinical trials sponsored by Suzhou Sanegene Bio Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New obesity drug SGB-7342 enters first human safety trial Results expected Oct 2026 (estimated)
- Can a single injection drug calm the immune attack on kidneys? Results expected Dec 2026 (estimated)
- Can a new injection tame the blood cell destruction of PNH? Results expected Aug 2027 (estimated)